5.58
Autonomix Medical Inc stock is traded at $5.58, with a volume of 47,533.
It is up +5.31% in the last 24 hours and up +29.37% over the past month.
Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.
See More
Previous Close:
$5.27
Open:
$5.19
24h Volume:
47,533
Relative Volume:
0.01
Market Cap:
$5.39M
Revenue:
-
Net Income/Loss:
$-16.72M
P/E Ratio:
-0.0871
EPS:
-64.0349
Net Cash Flow:
$-12.29M
1W Performance:
-18.98%
1M Performance:
+29.37%
6M Performance:
-30.30%
1Y Performance:
-73.83%
Autonomix Medical Inc Stock (AMIX) Company Profile
Name
Autonomix Medical Inc
Sector
Industry
Phone
832-277-7816
Address
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
Compare AMIX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
AMIX
Autonomix Medical Inc
|
5.55 | 5.74M | 0 | -16.72M | -12.29M | -64.03 |
|
ABT
Abbott Laboratories
|
115.73 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
330.00 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
92.61 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
49.87 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
89.91 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Autonomix Medical Inc Stock (AMIX) Latest News
Autonomix (AMIX) Momentum: Moves 10.83% Down to $5.27 in the Latest Reading; Trading Range: $5.01 and $5.53 Define the Nearby Reference Levels in the Current UpdateVolume Gap - Vinanet
Autonomix (AMIX) Earnings Reading: Profit Per Share Surpasses Its Benchmark at the Close; Share Response: The Stock Records a 4.21% Decrease in Latest TradingEPS Surprise History - Vinanet
Autonomix (AMIX) Quarterly Results: EPS Prints Above Forecast; After Earnings: Shares Fall 3.40% in the Current UpdateEarnings Decline Risk - Vinanet
Autonomix (AMIX) Quarterly Update: EPS Lands Above Forecast in the Current Update; Price Reaction: Shares Finish 5.86% Down in the Latest SessionSaaS Earnings Trends - Vinanet
Autonomix Medical completes pre-clinical study for FDA submission By Investing.com - Investing.com Nigeria
Autonomix Medical (AMIX) Holds at $6.85 as Narrow Trading Range Defines Near-Term OutlookETF Creation Redemption - Vinanet
Price to sales forward of Autonomix Medical, Inc. – NASDAQ:AMIX - TradingView
Autonomix Medical, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026 - marketscreener.com
Autonomix Medical Q1 Results: EPS of $(5.02) beats estimate - scanx.trade
Autonomix Medical (AMIX) flags going-concern risk and $25–$30M funding need - Stock Titan
Autonomix Medical, Inc. (AMIX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Autonomix Medical Stock Short Interest Rises to 50.21% - Moomoo
Autonomix Medical completes pre-clinical study for FDA submission - Investing.com
Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission - The Manila Times
Autonomix Medical Completes GLP Pre-Clinical Study, Advancing FDA Submission - Quiver Quantitative
Autonomix CMO Robert Schwartz receives lifetime award - Investing.com
Autonomix CMO Robert Schwartz receives cardiovascular award By Investing.com - Investing.com Australia
Autonomix CMO Robert Schwartz receives lifetime award By Investing.com - Investing.com South Africa
Autonomix CMO Robert Schwartz receives cardiovascular award - Investing.com
Autonomix Medical Congratulates Co-Founder & Chief Medical Officer Dr. Robert Schwartz on Receiving Prestigious 2026 Cardiovascular Tech Forum Lifetime Achievement Award - The Manila Times
Autonomix Medical Congratulates Chief Medical Officer Robert Schwartz on 2026 CTF Lifetime Achievement Award - Quiver Quantitative
Cardiovascular Innovator With 500+ Papers, 200+ Patents to Receive Award - Stock Titan
Why Autonomix Medical (AMIX) Stock Is Down Today - Quiver Quantitative
AMIX Stock Rockets On Resale News As Dilution Risks Build - StocksToTrade
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
AMIX Stock Rockets As Cash Deals Collide With Dilution Fears - StocksToTrade
Autonomix Medical Soars 434% as Patent Filings Indicate 2025 GrantThe Wall Street Journal - TechStock²
Autonomix Medical, Inc. SEC Filing (Aug 5, 2026) - Stock Titan
SpaceX, AMD, Nvidia, Astera Labs and Autonomix Medical: Why These 5 Stocks Are on Investors' Radars Today - Sahm
SPCX, AMD, NVDA, ALAB, AMIX: 5 Trending Stocks TodayAdvanced Micro Devices (NASDAQ:AMD) - Benzinga
Autonomix Medical receives patent for nerve-targeting cancer tech By Investing.com - Investing.com UK
$Autonomix Medical (AMIX.US)$ On at 17.31 sold shares at esch level above entry, holding runners - Moomoo
Autonomix Stock Skyrockets After Obtaining Key Cancer Tech Patent - benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Why Autonomix Medical Stock Has More Than Doubled Today - AskTraders
Autonomix Medical Receives U.S. Patent for Precision Neuromodulation Platform Expansion - Yahoo Finance
Why is Autonomix Medical stock surging today? By Investing.com - Investing.com India
Autonomix Medical receives patent for nerve-targeting cancer tech - Investing.com
AMIX Stock Whipsaws As Patent Wins And Data Fuel Speculation - timothysykes.com
Autonomix Medical Expands Precision Neuromodulation Platform with Broad New U.S. Patent Supporting Nerve Sensing, Mapping and Targeted Therapy - marketscreener.com
Autonomix patent covers mapping nerves tied to tumors and cancer pain - Stock Titan
Autonomix Medical secures U.S. patent for precision nerve sensing and cancer pain therapy - scanx.trade
$Autonomix Medical (AMIX.US)$ Its literally saying buy me here - Moomoo
$Autonomix Medical (AMIX.US)$ thats 21 PT hit next one at 37 - Moomoo
Autonomix Medical (AMIX) surges as traders react to recent renal-study data and fresh patent updates - Quiver Quantitative
Autonomix Medical, Inc. (NASDAQ:AMIX) rises as cash-per-share differential aligns with warrant overhang - TechStock²
Autonomix Medical stock halts, surges 116% on preclinical data - scanx.trade
Autonomix Medical Inc (AMIX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Autonomix Medical (AMIX) Stock Rallies Over 54% After Hours: Here's Why - Sahm
Autonomix Medical Inc (AMIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Autonomix Medical Inc (AMIX) Institutional Confidence - TradingKey
Autonomix Medical Inc Stock (AMIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):